These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29136600)

  • 1. Effects of venlafaxine versus lithium monotherapy on quality of life in bipolar II major depressive disorder: Findings from a double-blind randomized controlled trial.
    Lorenzo-Luaces L; Amsterdam JD
    Psychiatry Res; 2018 Jan; 259():455-459. PubMed ID: 29136600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.
    Amsterdam JD; Lorenzo-Luaces L; Soeller I; Li SQ; Mao JJ; DeRubeis RJ
    J Affect Disord; 2015 Oct; 185():31-7. PubMed ID: 26143402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD; Wang CH; Shwarz M; Shults J
    J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual anxiety may be associated with depressive relapse during continuation therapy of bipolar II depression.
    Lorenzo-Luaces L; Amsterdam JD; DeRubeis RJ
    J Affect Disord; 2018 Feb; 227():379-383. PubMed ID: 29149756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate.
    Amsterdam JD; Lorenzo-Luaces L; Soeller I; Li SQ; Mao JJ; DeRubeis RJ
    Br J Psychiatry; 2016 Apr; 208(4):359-65. PubMed ID: 26892848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid versus non-rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk.
    Lorenzo-Luaces L; Amsterdam JD; Soeller I; DeRubeis RJ
    Acta Psychiatr Scand; 2016 Jun; 133(6):459-69. PubMed ID: 26803764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
    Amsterdam JD; Shults J
    J Affect Disord; 2009 May; 115(1-2):234-40. PubMed ID: 18694599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-trial, aggregated, individual participant data mega-analysis of short-term antidepressant versus mood stabilizer monotherapy of bipolar type II major depressive episode.
    Amsterdam JD; Xu C
    Bipolar Disord; 2024 May; 26(3):255-264. PubMed ID: 37749069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials.
    Rajagopalan K; Bacci ED; Ng-Mak D; Wyrwich K; Pikalov A; Loebel A
    BMC Psychiatry; 2016 May; 16():157. PubMed ID: 27215976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Step-wise loss of antidepressant effectiveness with repeated antidepressant trials in bipolar II depression.
    Amsterdam JD; Lorenzo-Luaces L; DeRubeis RJ
    Bipolar Disord; 2016 Nov; 18(7):563-570. PubMed ID: 27805299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of efficacy in lithium augmentation for treatment-resistant depression.
    Sugawara H; Sakamoto K; Harada T; Ishigooka J
    J Affect Disord; 2010 Sep; 125(1-3):165-8. PubMed ID: 20089312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
    Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
    J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis.
    Goldberg JF; Harrow M
    J Affect Disord; 2005 Dec; 89(1-3):79-89. PubMed ID: 16249035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
    Alevizos B; Alevizos E; Leonardou A; Zervas I
    Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    Sachs GS; Ice KS; Chappell PB; Schwartz JH; Gurtovaya O; Vanderburg DG; Kasuba B
    J Clin Psychiatry; 2011 Oct; 72(10):1413-22. PubMed ID: 21672493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS; Vanderburg DG; Karayal ON; Kolluri S; Bachinsky M; Cavus I
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use.
    Ghaemi SN; Goodwin FK
    J Affect Disord; 2001 Aug; 65(3):281-7. PubMed ID: 11511408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.
    Altshuler LL; Post RM; Hellemann G; Leverich GS; Nolen WA; Frye MA; Keck PE; Kupka RW; Grunze H; McElroy SL; Sugar CA; Suppes T
    J Clin Psychiatry; 2009 Apr; 70(4):450-7. PubMed ID: 19358785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.